Northern Trust’s MIRA Pharmaceuticals MIRA Stock Holding History

Northern Trust’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.4K	Hold	67,698	–	–	﹤0.01%	4177
2025 Q4	$102K	Buy	67,698 +23,966	+55%	+$35.2K	﹤0.01%	4135
2025 Q3	$59.5K	Buy	43,732 +30,137	+222%	+$43.7K	﹤0.01%	4252
2025 Q2	$16.4K	Hold	13,595	–	–	﹤0.01%	4352
2025 Q1	$13.3K	Sell	13,595 -16,767	-55%	-$19.1K	﹤0.01%	4373
2024 Q4	$34.6K	Buy	30,362 +10,238	+51%	+$13.4K	﹤0.01%	4315
2024 Q3	$26.2K	Sell	20,124 -330	-2%	-$526	﹤0.01%	4310
2024 Q2	$13K	Hold	20,454	–	–	﹤0.01%	4363
2024 Q1	$22.5K	Hold	20,454	–	–	﹤0.01%	4321
2023 Q4	$21.5K	Buy	+20,454	New	+$52K	﹤0.01%	4355

Other funds holding MIRA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust's MIRA Position: Q1 2026 in Review

Northern Trust held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 67,698 shares worth $72.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.

Northern Trust first reported a position in MIRA in Q4 2023 and has held it in 10 quarters since. The position peaked at $102K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

Northern Trust held 67,698 shares of MIRA Pharmaceuticals worth $72.4K as of Q1 2026.
Northern Trust left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
MIRA Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4177 holding.
Northern Trust first reported a position in MIRA Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Northern Trust's MIRA Pharmaceuticals position peaked at $102K in Q4 2025.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.